This Government Contract opportunity from Department Of Veterans Affairs was posted on January 21, 2025. The submission period has ended. Browse the details below for market research, or find similar active opportunities.

Top

6505--Notice of Intent - Radiopharmaceuticals Bridge

Closed

36C25725Q0241Federal

Submission Closed01/23/2025, 11:00:00 PM UTC

Contract Overview

Solicitation details, issuing organization, response deadlines, documents, and interested companies for this government contract opportunity.

Active Opportunities Like This One

NAICS: 325412

New

DIBBS

Supply of Bupivacaine Hydrochloride InjectionThis subcontract involves the supply of pharmaceutical-grade Bupivacaine Hydrochloride Injection, USP, 0.5%, 50 ML (NSN: 6505001387347) to prime contractors supporting Department of Defense DLA Troop Support medical supply contracts. The agreement requires the delivery of 2,000 units within a strict five-day window, ensuring all products meet USP standards and possess a minimum shelf-life of 24 months. To maintain product integrity, the supplier must utilize climate-controlled logistics to keep the injections within a temperature range of 20 to 25 degrees Celsius. This procurement is managed under NAICS code 325412 through the Medical Supply Chain Pharm FSA.

MEDICAL SUPPLY CHAIN PHARM FSA

POSTED

DEADLINE

ARTIFICIAL TEARS SOLUT

Solicitation # SPE2DP-27-T-0204

Solicitation SPE2DP-27-T-0204 is a small business set-aside issued by the DLA Troop Support Medical Supply Chain Pharm FSA for the procurement of 40 bottles of 1.4% artificial tears solution (NSN 6505009617486), each with a 15 ML capacity. The contract requires a non-extendable shelf life of 36 months and specifies delivery to the USS NITZE DDG 94. Delivery is required within 20 days after receipt of order, with an original required delivery date of October 28, 2026. The terms are FOB Destination, and both inspection and acceptance will occur at the destination. The contractor must adhere to strict packaging and marking standards, primarily Medical Marking Standard No. 1, which supersedes MIL-STD-129. Packaging must be commercial and sealed in suitable containers to prevent damage, with palletization following DLA requirement RP001. If the material is deemed hazardous per FED-STD-313, it must be packaged according to TQ requirement IP025 and labeled per the Hazard Communication Standard; otherwise, ASTM D3951 applies. Invoicing must be processed electronically through the Wide Area WorkFlow system. The award process includes a HUBZone price evaluation preference, and any offers utilizing additive manufacturing are ineligible for award.

MEDICAL SUPPLY CHAIN PHARM FSA

POSTED

DEADLINE

PERMETHRIN CREAM RINSE

Solicitation # SPE2DP-27-T-0202

This solicitation, issued by the DLA Troop Support Medical Supply Chain Pharm FSA, is a small business set-aside for the procurement of six units of Permethrin Cream Rinse (NSN 6505-01-256-4972). The required product is a 1% W/V Permethrin active ingredient supplied in a 2 fl oz plastic squeeze bottle and must include a comb. The item is FDA-regulated and has a total shelf life of 24 months, with a mandatory minimum of 21 months remaining upon receipt by the government. Delivery is required within five days after receipt of order (ADO) to a destination in Poland. The contract mandates strict adherence to medical and hazardous material standards, requiring marking in accordance with Medical Marking Standard No. 1 and packaging per MIL-STD-2073-1E. Suppliers must provide Safety Data Sheets (SDS) and Hazardous Communication Standard labels prior to award, with a copy of the SDS accompanying each shipment. Invoicing must be processed through the Wide Area WorkFlow (WAWF) system. Key regulatory clauses include the Buy American Act, DFARS cybersecurity reporting requirements, and the prohibition of additive manufacturing processes for the provided items. Inspection and acceptance will occur at the destination.

MEDICAL SUPPLY CHAIN PHARM FSA

POSTED

DEADLINE

BUPIVACAINE HYDROCHLOR

Solicitation # SPE2DP-27-T-0203

Solicitation SPE2DP-27-T-0203, issued by the DLA Troop Support Medical Supply Chain Pharm FSA, is a small business set-aside for the procurement of Bupivacaine Hydrochloride Injection, USP, 0.5%, 50 ML. The requirement consists of two units under NSN 6505001387347, with a non-extendable shelf life of 24 months. The product is FDA-regulated and must be stored between 20 to 25 degrees Celsius. Delivery is required within five days of award, with an original required delivery date of October 30, 2026, shipped FOB Destination to the US Army SSA in Powidz, Poland. The contract mandates strict adherence to Medical Marking Standard No. 1, which supersedes MIL-STD-129 for medical materials. Packaging must be commercial, utilizing sealed unit containers and exterior shipping containers compliant with MIL-STD-2073-1E and DLA packaging requirements for palletization. Inspection and acceptance will occur at the destination per FAR 52.246-2. Administrative requirements include the use of the Wide Area WorkFlow system for electronic invoicing and payment. The solicitation incorporates various FAR and DFARS clauses regarding hazardous material identification, cybersecurity reporting, and domestic origin preferences under the Buy American Act.

MEDICAL SUPPLY CHAIN PHARM FSA

POSTED

DEADLINE

Atropine Autoinjector Manufacturing

POSTED

DEADLINE

Cell Separation and Processing Reagent Supplier

242-NETWORK Contract Office 02 (36C242)

POSTED

DEADLINE

Laboratory Quality Control (QC) Material Supplier

242-NETWORK Contract Office 02 (36C242)

POSTED

DEADLINE

Atropine Auto-Injector

Solicitation # SPE2DP-27-R-ATRO

DLA Troop Support is conducting market research via a sources sought notice for the procurement of Atropine Auto-Injectors under solicitation SPE2DP-27-ATRO. The agency intends to award a firm-fixed price, indefinite delivery, indefinite quantity contract consisting of a one-year base term and four one-year option terms. The required devices must deliver 1.67 mg of atropine base (equivalent to 2 mg atropine sulfate) and be 99.5 percent reliable, with a dispensing time of 0.5 seconds and an activation force between 0.90 and 3.60 kg. All products must be FDA approved per NDA No. 212319, comply with USP sterility standards, and maintain a minimum shelf life of 24 months upon delivery to DLA Distribution Susquehanna in New Cumberland, Pennsylvania. Strict packaging and marking requirements are mandated, including individual sealed polyethylene bags, intermediate boxes of 40 units, and exterior containers of 480 units, all conforming to MIL-STD-2073-1 and ASTM D4169-16. Labels must include specific dosage, storage, and usage instructions for nerve agent and insecticide poisoning. Interested respondents must provide their CAGE code, business size under NAICS 325412, and certification of commerciality per FAR 2.101. Manufacturers must submit FDA registration, while authorized distributors must provide a letter of commitment from the manufacturer. Responses are due by December 1, 2026.

POSTED

DEADLINE

Supply of Electrical Insulation Tape (NSN 5970-01-012-4280)This subcontract involves the supply of electrical insulation tape, identified by NSN 5970-01-012-4280, for prime contractors working on DLA Weapons Support ASC projects. The contractor is required to provide two rolls of tape delivered FOB Origin to Evenes Airbase. All materials must strictly conform to technical specification BASIC CID A-A-59474D, Revision D, and adhere to MIL-STD-2073-1E and RP001 for packaging and MIL-STD-129 for marking. To be eligible, the supplier must hold either SAE AS9003 or ISO 9001 certification and maintain full compliance with DFARS 252.204-7012. This procurement is managed by the Department of Defense under the DLA Weapons Support ASC Supplier Oper AE and AF Div, with a response deadline set for November 5, 2026.

DLA WEAPONS SUPPORT ASC SUPPLIER OPER AE AND AF DIV

POSTED

DEADLINE

Sterile X-Ray Detectable Packing Gauze SupplierThis subcontract involves the supply of 640 units of sterile, medical-grade packing gauze for prime contractors supporting Department of Defense medical supply contracts. The required product is a 1-ply, soft, white Z-fold gauze measuring 3 inches by 5 yards, featuring an embedded X-ray detectable line. To ensure clinical safety and longevity, the gauze must be sterilized to medical standards to maintain a shelf life of 60 months. The contract is managed under the Medical Supply Chain MD Surg FSF and requires strict adherence to the Berry Amendment and the Buy American Act for NSN 6510-01-695-5824. Performance for this requirement is centered in San Diego, California. Interested parties must note the response deadline of November 3, 2026.

MEDICAL SUPPLY CHAIN MD SURG FSF

POSTED

DEADLINE

Supply of Tolnaftate Powder (USP 1%)This subcontract involves the supply of Tolnaftate Powder, USP 1%, to prime contractors supporting the Department of Defense Medical Supply Chain Pharm FSA. The requirement specifies the delivery of two bottles of pharmaceutical product, with each unit consisting of a 45 GM sealed container. All supplies must strictly adhere to United States Pharmacopeia standards and utilize commercial packaging and packing methods to ensure the integrity of the contents. The opportunity is categorized under NAICS code 325412 and is associated with a performance location in FPO 96678. Interested parties must note the response deadline of November 3, 2026, following the posting date of October 28, 2026.

MEDICAL SUPPLY CHAIN PHARM FSA

POSTED

DEADLINE

Supplier of Disposable PVP Iodine ApplicatorsThis subcontract involves the supply of individually packaged disposable PVP Iodine swab sticks to prime contractors supporting Department of Defense medical supply contracts through DLA Troop Support. The required product must match NSN 6515-01-519-2226, utilizing medical-grade Povidone-Iodine solution and medical-grade packaging. Each delivery unit consists of packages containing 50 applicators. Strict quality and timing standards are mandated, requiring a minimum shelf life of 15 months and delivery within two months of the date of manufacture. The contract is categorized under NAICS code 325412 and is managed by the Medical Supply Chain MD Surg FSF. Performance for this requirement is designated for FPO 09592-4700.

MEDICAL SUPPLY CHAIN MD SURG FSF

POSTED

1 day ago

DEADLINE

in 5 days

General Info

Agency

Department Of Veterans Affairs → 257-NETWORK Contract Office 17 (36C257)

NAICS

325412 - Pharmaceutical Preparation Manufacturing

Place of Performance

Set-Aside

NONE

Documents

36C25725Q0241 - Notice of Intent - Radiopharmaceuticals Bridge

special-notice

Low

AI Contract Breakdown

Uniform Contract Format

Timeline

PhaseClosed

PostedJan 21

special-notice

Response DeadlineJan 23

Deadline has passed

Submission Closed

01/23/2025, 11:00:00 PM UTC

Find active opportunities like this

Get full access to discover similar active contracts, track opportunities, and build proposals with AI assistance.

Organization & Contact Information

AgencyDepartment Of Veterans Affairs → 257-NETWORK Contract Office 17 (36C257)

Contacts1 person available

OfficeSan Antonio, TX, 78240, USA

Organization / AgencyDepartment Of Veterans Affairs → 257-NETWORK Contract Office 17 (36C257)

Office AddressSan Antonio, TX, 78240, USA

Contacts

Vance FarrellContract Specialist

contact@example.gov

+1 (555) 000-0000

Full Description

Special Notice Notice of Intent to Award a Sole Source Procurement The Department of Veterans Affairs, Veterans Health Administration, Network Contracting Office 17, intends to place a sole source firm-fixed priced order with Panhandle Nuclear RX LTD for the procurement of the following items: 0001: I-123 100uCi Capsule, Unit of Issue: EA, Qty.: 15 0002: I-123 200uCi Capsule, Unit of Issue: EA, Qty.: 15 0003: I-123 MIBT, Unit of Issue: EA, Qty.: 2 0004: In-111 WBC, Unit of Issue: EA, Qty.: 5 0005: In-111 Octreoscan, Unit of Issue: EA, Qty.: 5 0006: Tc-99m 04 30 mCi, Unit of Issue: EA, Qty: 30 0007: Tc-99m 04 1-5 mCi, Unit of Issue: EA, Qty.: 75 0008: Tc-99m 04 50 mCi, Unit of Issue: EA, Qty.: 4 0009: Tc-99m Ceretec WBC, Unit of Issue: EA, Qty.: 2 0010: Tc-99m Choletec 5-8 mCi, Unit of Issue: EA, Qty.: 70 0011: Tc-99m MAA 5 mCi, Unit of Issue: EA, Qty.: 60 0012: Tc-99m MAG3, Unit of Issue: EA, Qty.: 275 0013: Tc-99m MDP 25 mCi, Unit of Issue: EA, Qty.: 200 0014: Tc-99m Sestamibi 11-30mCi, Unit of Issue: EA, Qty.: 500 0015: Tc-99m Sestamibi 25 mCi, Unit of Issue: EA, Qty.: 5 0016: Tc-99m Sulfur Colloid 1-8 mCi, Unit of Issue: EA, Qty.: 25 0017: Tc-99m Filtered Sulfur Colloid 1 mCi, Unit of Issue: EA, Qty.: 5 0018: Tc-99m DTPA, Unit of Issue: EA, Qty.: 1 0019: Tc-99m PYP, Unit of Issue: EA, Qty.: 1 0020: Thallium 6 mCi, Unit of Issue: EA, Qty.: 1 0021: Thallium 4 mCi, Unit of Issue: EA, Qty.: 1 0022: Xenon 133 Gas 10-30 mCi, Unit of Issue: EA, Qty.: 60 0023: Gallium Citrate 10 mCi, Unit of Issue: EA, Qty.: 2 0024: Ultratag RBC Kit, Unit of Issue: EA, Qty.: 15 0025: Co-57 Flood Source 10 mCi, Unit of Issue: EA, Qty.: 1 0026: Co-57 Source Markers (3), Unit of Issue: EA, Qty.: 1 The requested items are needed for patient care at the Amarillo VA Health Care System, Amarillo, TX. The proposed sole source procurement will be made by an open market pricing agreement with Panhandle Nuclear RX LTD. Market research identified that Panhandle Nuclear RX LTD is the only nuclear pharmacy in the Amarillo TX area. The nuclear pharmacy must be in close proximity to the delivery location due to the limited shelf-life of the radiopharmaceutical items. The contractor must be licensed by the US Nuclear Regulatory Commission (USNRC), or a State with a formal agreement with the USNRC that allows the State to regulate radioactive materials. This notice is not to be considered a request for quotations or proposals. No contract will be awarded based on offers received in response to this notice; however, all responsible sources may submit a capability statement, proposal, or quotation, which shall be considered by the agency. Proposals or offers received will be used to determine if a comparable source is available and more advantageous to the government. If no affirmative written response is received within 2 days from the publication of this notice, a contract or order will be issued to Panhandle Nuclear RX LTD without any further notice. The anticipated statutory authority permitting other than full and open competition for the requirement is 41 U.S.C. 3304(a)(1), as implemented by FAR 6.302-1, only one responsible source and no other supplies or services will satisfy agency requirements.